DWM
GSK icon

Darwin Wealth Management’s GSK GSK Stock Holding History

Darwin Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Buy
+432
New +$22.8K 0.01% 315
2026
Q1 		– Hold
0
– – – 592
2020
Q2 		– Sell
-280
Closed -$13K – 395
2020
Q1 		$13K Buy
+280
New +$14.9K ﹤0.01% 421

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Darwin Wealth Management's GSK Position: Q2 2026 in Review

Darwin Wealth Management opened a new position in GSK (GSK) in Q2 2026: 432 shares worth $22.6K. The stake represents 0.01% of the portfolio and ranks #315 among its holdings. This is a return to the name: Darwin Wealth Management previously reported a position in GSK as recently as Q1 2020.

Darwin Wealth Management first reported a position in GSK in Q1 2020 and has held it in 2 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Darwin Wealth Management held 432 shares of GSK worth $22.6K as of Q2 2026.
  • GSK was a new Darwin Wealth Management position in Q2 2026.
  • GSK made up 0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #315 holding.
  • Darwin Wealth Management first reported a position in GSK in Q1 2020 and has held it in 2 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.